Study of a fertility drug for women undergoing IVF with frozen embryo transfer
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a medication called human menopausal gonadotropin to help women undergoing IVF achieve a live birth. It focuses on the cumulative success rate after freezing and later transferring embryos.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 18 to 42 and have regular menstrual cycles between 21–35 days
- Have a body mass index (BMI) between 18 and 38
- Have a certain hormone level (AMH) above 1.2 ng/ml, indicating good egg supply
- No major uterine or ovarian issues, and both ovaries are visible on ultrasound
- Willing to undergo up to two egg retrieval cycles and accept transfer of one genetically normal embryo
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
This trial tests whether adding a GnRH agonist medication before a frozen embryo transfer can improve success rates. It may help women undergoing their first or second frozen embryo transfer who have good quality embryos.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.